:

Homeland Security

Cleveland BioLabs Completes Manufacturing Process for Radiation Drug

DDN

Wednesday, October 31st, 2007

SHARE:

Cleveland BioLabs [CBLI] has completed the technology transfer to its manufacturing partner for Protectan CBLB502, which the company has developed for medical radiation countermeasures to treat gastrointestinal effects of acute radiation syndrome. Production of the first Good Manufacturing Practices compliant batch of Protectan was also completed ahead of schedule. Cleveland BioLabs submitted Protectan in response to a Defense Department Request for Proposals. A contract would provide funding for development of the countermeasure through approval by the Food and Drug Administration,…

Congress

HASC’s Final FY ‘27 NDAA Expands Systems Eligible For Multi-Years, Includes LTAMDS, IBCS, ARRW

House defense authorizers added a measure to their version of the next defense policy bill that would expand the list of weapons platforms eligible for multi-year contracts, to include the […]

Congress

HASC Bill Would Allow Air Force To Buy More Than 267 F-15EXs

The House Armed Services Committee’s (HASC) fiscal 2027 defense authorization bill would allow the Air Force to buy more than 267 F-15EX fighters by Boeing [BA] and would extend the […]

Budget

Defense Bill Tries To Block Foreign Shipbuilding, Adds $1 Billion For Second DDG

The final version of the House Armed Services Committee’s (HASC) fiscal year 2027 defense authorization bill included two amendments pushed by Rep. Jared Golden (D-Maine) that restrict procuring Navy warships […]

Congress

Replacement Munitions May Not Be One-for-One; May Include New Weapons Chemistries, Wittman Says

As the Pentagon looks to refill inventories of weapons used in Iran and elsewhere, replacements may not be one for one but instead mark a new portfolio mix, according to […]